PSI Supports Alchemia in the ‘Ride to Conquer Cancer”

ZUG, Switzerland--(BUSINESS WIRE)--PSI-CRO heartily congratulates the Alchemia team on their success in the “Ride to Conquer Cancer’ which took place in Brisbane, Australia over the weekend of August 18-19. PSI is currently providing clinical trial services for Alchemia’s development of HA-Irinotecan and was delighted to be the team’s main sponsor for the cycling fundraiser.

“Ride to Conquer Cancer’ which took place in Brisbane, Australia over the weekend of August 18-19. PSI is currently providing clinical trial services for Alchemia’s development of HA-Irinotecan and was delighted to be the team’s main sponsor for the cycling fundraiser.”

The Alchemia team each rode for more than 200 km and were well-placed in the top 10% of the finishers. The event raised AUD 5.2 Million with proceeds helping to fund the translation of discoveries into oncology treatments, diagnostics and prevention strategies at the Queensland Institute of Medical Research.

About PSI CRO AG: PSI (www.psi-cro.com) is a privately-held, full-service CRO, operating globally with 1,200 employees worldwide. Global headquarters are located in Zug, Switzerland at 113a Baarerstrasse 6300.